FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897815770> ?p ?o ?g. }

• W2897815770 abstract "Currently, several studies have demonstrated that PRKAA1 polymorphisms conduce to the development of cancer. PRKAA1 gene encodes the AMP-activated protein kinase summit-α1, and plays an important role in cell metabolism. Thus, we performed a systematic review and meta-analysis of all enrolled eligible case-control studies to obtain a precise correlation between PRKAA1 polymorphism and cancer susceptibility. Extensive retrieve was performed in Web of Science, Google Scholar, PubMed, EMbase, CNKI and Wanfang databases up to August 26, 2018. Odds ratios (ORs) and 95% CIs were performed to evaluate the overall strength of the associations in five models, as well as in subgroup analyses, stratified by ethnicity, cancer type or source of control. Q-test, Egger’s test and Begg’s funnel plot were applied to evaluate the heterogeneity and publication bias. In-silico analysis was performed to demonstrate the relationship of PRKAA1 expression correlated with cancer tissues and survival time. Twenty-two case-control studies from 14 publications were enrolled, with 17,068 cases and 20,871 controls for rs13361707, and 2514 cases and 3193 controls for rs10074991. Overall, we identified that the PRKAA1 rs13361707 polymorphism is not significantly associated with cancer susceptibility under all five genetic models. For rs10074991, we revealed a significant decrease risk in allelic comparison model (B vs. A: OR = 0.774, 95% CI = 0.642–0.931, PAdjust = 3.376*10− 2), heterozygote comparison model (BA vs. AA: OR = 0.779 95%CI = 0.691–0.877, PAdjust = 9.86*10− 10;), and dominant genetic model (BB + BA vs. AA: OR = 0.697 95%CI = 0.533–0.912, PAdjust = 4.211*10− 2;). Evidence from TCGA database and GTEx projects indicated that the expression of PRKAA1 in gastric cancer tissue is higher, compared to normal stomach tissue, as well as it in breast cancer and esophageal squamous cell carcinoma. However, the Kaplan-Meier estimate showed that there is no significant difference of OS and RFS between the low and high PRKAA1 TPM groups in gastric cancer, breast cancer, and esophageal carcinoma. To sum up, PRKAA1 rs13361707 polymorphism is not participant with the increased risk of cancer, while the A allele of PRKAA1 rs10074991 revealed a significant decrease risk." @default.
• W2897815770 created "2018-10-26" @default.
• W2897815770 creator A5005278584 @default.
• W2897815770 creator A5011853582 @default.
• W2897815770 creator A5025160212 @default.
• W2897815770 creator A5074140059 @default.
• W2897815770 creator A5083417334 @default.
• W2897815770 date "2018-10-19" @default.
• W2897815770 modified "2023-09-30" @default.
• W2897815770 title "Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review" @default.
• W2897815770 cites W1548553702 @default.
• W2897815770 cites W1598059204 @default.
• W2897815770 cites W1690573735 @default.
• W2897815770 cites W1768132019 @default.
• W2897815770 cites W1964435302 @default.
• W2897815770 cites W1969345529 @default.
• W2897815770 cites W1970205234 @default.
• W2897815770 cites W1979656912 @default.
• W2897815770 cites W1982154889 @default.
• W2897815770 cites W1988848089 @default.
• W2897815770 cites W1990925757 @default.
• W2897815770 cites W2007872832 @default.
• W2897815770 cites W2015366551 @default.
• W2897815770 cites W2022720370 @default.
• W2897815770 cites W2028207888 @default.
• W2897815770 cites W2035651268 @default.
• W2897815770 cites W2046521127 @default.
• W2897815770 cites W2046674021 @default.
• W2897815770 cites W2076689971 @default.
• W2897815770 cites W2084187927 @default.
• W2897815770 cites W2088181514 @default.
• W2897815770 cites W2090241102 @default.
• W2897815770 cites W2100578773 @default.
• W2897815770 cites W2107315098 @default.
• W2897815770 cites W2107328434 @default.
• W2897815770 cites W2117275311 @default.
• W2897815770 cites W2129224427 @default.
• W2897815770 cites W2138792619 @default.
• W2897815770 cites W2149418478 @default.
• W2897815770 cites W2150000105 @default.
• W2897815770 cites W2157823046 @default.
• W2897815770 cites W2159664830 @default.
• W2897815770 cites W2170880090 @default.
• W2897815770 cites W2174118934 @default.
• W2897815770 cites W2345029350 @default.
• W2897815770 cites W2531029239 @default.
• W2897815770 cites W2591065097 @default.
• W2897815770 cites W2607129810 @default.
• W2897815770 cites W2616653782 @default.
• W2897815770 cites W2771583858 @default.
• W2897815770 cites W2883603023 @default.
• W2897815770 cites W910021155 @default.
• W2897815770 doi "https://doi.org/10.1186/s12881-018-0704-8" @default.
• W2897815770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6194619" @default.
• W2897815770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30340465" @default.
• W2897815770 hasPublicationYear "2018" @default.
• W2897815770 type Work @default.
• W2897815770 sameAs 2897815770 @default.
• W2897815770 citedByCount "6" @default.
• W2897815770 countsByYear W28978157702020 @default.
• W2897815770 countsByYear W28978157702022 @default.
• W2897815770 countsByYear W28978157702023 @default.
• W2897815770 crossrefType "journal-article" @default.
• W2897815770 hasAuthorship W2897815770A5005278584 @default.
• W2897815770 hasAuthorship W2897815770A5011853582 @default.
• W2897815770 hasAuthorship W2897815770A5025160212 @default.
• W2897815770 hasAuthorship W2897815770A5074140059 @default.
• W2897815770 hasAuthorship W2897815770A5083417334 @default.
• W2897815770 hasBestOaLocation W28978157701 @default.
• W2897815770 hasConcept C104317684 @default.
• W2897815770 hasConcept C126322002 @default.
• W2897815770 hasConcept C143998085 @default.
• W2897815770 hasConcept C156957248 @default.
• W2897815770 hasConcept C180754005 @default.
• W2897815770 hasConcept C187960798 @default.
• W2897815770 hasConcept C2780439572 @default.
• W2897815770 hasConcept C2992519594 @default.
• W2897815770 hasConcept C54355233 @default.
• W2897815770 hasConcept C71924100 @default.
• W2897815770 hasConcept C82605166 @default.
• W2897815770 hasConcept C86803240 @default.
• W2897815770 hasConcept C95190672 @default.
• W2897815770 hasConceptScore W2897815770C104317684 @default.
• W2897815770 hasConceptScore W2897815770C126322002 @default.
• W2897815770 hasConceptScore W2897815770C143998085 @default.
• W2897815770 hasConceptScore W2897815770C156957248 @default.
• W2897815770 hasConceptScore W2897815770C180754005 @default.
• W2897815770 hasConceptScore W2897815770C187960798 @default.
• W2897815770 hasConceptScore W2897815770C2780439572 @default.
• W2897815770 hasConceptScore W2897815770C2992519594 @default.
• W2897815770 hasConceptScore W2897815770C54355233 @default.
• W2897815770 hasConceptScore W2897815770C71924100 @default.
• W2897815770 hasConceptScore W2897815770C82605166 @default.
• W2897815770 hasConceptScore W2897815770C86803240 @default.
• W2897815770 hasConceptScore W2897815770C95190672 @default.
• W2897815770 hasFunder F4320321001 @default.
• W2897815770 hasIssue "1" @default.
• W2897815770 hasLocation W28978157701 @default.
• W2897815770 hasLocation W28978157702 @default.
• W2897815770 hasLocation W28978157703 @default.

• next